Concerns have been raised about the various implications the COVID-19 pandemic can have for people living with HIV and different communities affected by HIV, as well as for healthcare systems. There are also opportunities and solutions to be found. The European AIDS Treatment Group, as a network of people living with and affected by HIV and partners in Europe and Central Asia, supports community reporting and exchange between members and partners to support mutual learning and advocacy at local or European levels.
This rapid assessment aims to document in a structured manner the perceptions of people living with and affected by HIV and that of organisations providing services to affected communities about the way in which COVID-19 impacts their health, well-being and access to HIV related prevention, treatment and care. This assessment has its limitations and biases (little time to develop the tool, questionnaire only available online and only in English, limited time the survey was open). Nonetheless, this rapid assessment provides a snapshot of information, concerns and solutions shared by respondents in several countries during the week of 27 March to 3 April 2020.
Respondents include those from Romania, Albania, Slovenia and Greece.
The rapid assessment is available following this link>>>
The Principal Recipient for Kosovo is the
Aim of the
The RADIAN ‘Unmet Need’ fund will support local initiatives across the EECA region. Initiatives selected will focus on prevention and care, education, community empowerment, and novel partnerships. The programme will be implemented locally, working with key stakeholders and partners.
Marios Atzemis was one of the Greek drug users diagnosed with HIV in 2011. He had been addicted to heroin and a regular in Athens’ open-air drug markets well before the crisis. Then in 2010, street services to help drug users stay safe lost a third of their funding. Atzemis stopped seeing the vans that used to distribute fresh syringes, even as new users were entering the scene, shooting newer, cheaper drugs.
